Company / Operating Cash Flow per Share
Ernexa Therapeutics Inc. Operating Cash Flow per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.62
FY2025
5-year range
-$4.62 / $0.95
FY2021-FY2025
Trend
-22.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-4.62 in FY2025 to $0.95 in FY2020.
Based on SEC 10-K filings.
-4.62 in FY2025.
Declined from $-4.09 to $-4.62 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 22.5% year-over-year.
- Peak operating cash flow per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.62 | -22.5% |
| FY2024 | -$3.77 | +7.8% |
| FY2023 | -$4.09 | -532.5% |
| FY2020 | $0.95 | +99.2% |
| FY2019 | $0.47 | +118.0% |
| FY2018 | $0.22 | +87424.1% |
| FY2017 | $0.00 | +100.0% |
| FY2016 | -$2.26 | -3170.5% |
| FY2015 | -$0.07 | -412.3% |
| FY2014 | $0.02 | -27.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026